Showing results (561-570 of 994) with videos related to
Sort By:
Pageof 100
Journal of Pharmaceutical Policy and Practice|February 11, 2025
Comparing Beers, STOPP and MALPIP criteria in detecting potentially inappropriate medications, clinical outcomes, and cost impacts among older Malaysians: a cohort studyChee Tao Chang, Huan-Keat Chan, Aie Yen Tan, et al.Journal of Pharmaceutical Policy and Practice|February 11, 2025
Beliefs of patients who visited community pharmacies about medicines and supplements, the need for drug therapy and medication adherence - a cross-sectional studyEtidal-Mihaela Manoliu-Hamwi, Cristina Gena Dascălu, Cristina Mihaela Ghiciuc, et al.Journal of Pharmaceutical Policy and Practice|February 19, 2025
Home blood pressure during night-time sleep - a feasible treatment target for patients with hypertension: a proof-of-concept randomised controlled trialEric Kam-Pui Lee, Shuqi Wang, Benjamin Hon-Kei Yip, et al.Journal of Pharmaceutical Policy and Practice|February 19, 2025
Cost-effectiveness analysis of a first-line treatment with cadonilimab plus platinum-based chemotherapy with or without bevacizumab for persistent, recurrent, or metastatic cervical cancer in China: COMPASSION-16 trialYiling Ding, Chunping Wang, Yamin Shu, et al.Journal of Pharmaceutical Policy and Practice|February 19, 2025
Expanding access to NCD services via community retail pharmacies in LMICs: a systematic review of the literatureArianna Gentilini, Lombe Kasonde, Zaheer-Ud-Din BabarJournal of Pharmaceutical Policy and Practice|February 7, 2025
Medication-focused telehealth interventions to reduce the hospital readmission rate: a systematic reviewFatemeh Emadi, Racha Dabliz, Rebekah Moles, et al.Journal of Pharmaceutical Policy and Practice|August 7, 2024
Barriers to access to antihypertensive medicines: insights from the HEARTS initiative in latin American and Caribbean regionKathiaja Miranda Souza, Nora Giron, Juliana Vallini, et al.Journal of Pharmaceutical Policy and Practice|June 21, 2024
Do newer drugs treat fewer diseases, controlling for time since launch? Evidence from France and the U.SFrank R LichtenbergJournal of Pharmaceutical Policy and Practice|January 19, 2023
Using Failure Mode, Effect and Criticality Analysis to improve safety in the cancer treatment prescription and administration processAlessandra Buja, Giuseppe De Luca, Ketti Ottolitri, et al.Journal of Pharmaceutical Policy and Practice|January 17, 2023
A pharmacist check of patients' infection-related condition prior to drug preparation reduces anticancer drug wastage after mixing: a retrospective studyHirotsugu Yamada, Yuto Yamada, Hirotoshi Iihara, et al.Pageof 100